[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0623012D0 - Diphyllin and other lignans as a medicament for V-ATPase mediated disease - Google Patents

Diphyllin and other lignans as a medicament for V-ATPase mediated disease

Info

Publication number
GB0623012D0
GB0623012D0 GBGB0623012.2A GB0623012A GB0623012D0 GB 0623012 D0 GB0623012 D0 GB 0623012D0 GB 0623012 A GB0623012 A GB 0623012A GB 0623012 D0 GB0623012 D0 GB 0623012D0
Authority
GB
United Kingdom
Prior art keywords
diphyllin
lignans
medicament
mediated disease
atpase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0623012.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordic Bioscience AS
Original Assignee
Nordic Bioscience AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordic Bioscience AS filed Critical Nordic Bioscience AS
Priority to GBGB0623012.2A priority Critical patent/GB0623012D0/en
Publication of GB0623012D0 publication Critical patent/GB0623012D0/en
Priority to PCT/EP2007/062081 priority patent/WO2008058897A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
GBGB0623012.2A 2006-11-17 2006-11-17 Diphyllin and other lignans as a medicament for V-ATPase mediated disease Ceased GB0623012D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0623012.2A GB0623012D0 (en) 2006-11-17 2006-11-17 Diphyllin and other lignans as a medicament for V-ATPase mediated disease
PCT/EP2007/062081 WO2008058897A2 (en) 2006-11-17 2007-11-08 Diphyllin and other lignans as a medicament for v-atpase mediated disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0623012.2A GB0623012D0 (en) 2006-11-17 2006-11-17 Diphyllin and other lignans as a medicament for V-ATPase mediated disease

Publications (1)

Publication Number Publication Date
GB0623012D0 true GB0623012D0 (en) 2006-12-27

Family

ID=37605523

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0623012.2A Ceased GB0623012D0 (en) 2006-11-17 2006-11-17 Diphyllin and other lignans as a medicament for V-ATPase mediated disease

Country Status (2)

Country Link
GB (1) GB0623012D0 (en)
WO (1) WO2008058897A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012045451A1 (en) 2010-10-05 2012-04-12 Ludwig-Maximilians-Universitaet Muenchen Novel therapeutic treatment of progranulin-dependent diseases
CN102070645B (en) * 2011-01-07 2015-04-22 兰州大学 Deoxy-podophyllotoxin type compound and preparation and application thereof
JP5643123B2 (en) * 2011-01-21 2014-12-17 花王株式会社 Whitening agent
WO2012099247A1 (en) * 2011-01-21 2012-07-26 花王株式会社 Skin whitening agent
JP5588408B2 (en) * 2011-09-01 2014-09-10 花王株式会社 Whitening agent
IN2014MN00174A (en) * 2011-06-30 2015-06-19 Godavari Biorefineries Ltd
CN102516333A (en) * 2011-12-09 2012-06-27 南通大学 Diphyllin1,2-trans-permethoxy glucoside, its preparation method and application thereof
CN104370982B (en) * 2014-05-19 2017-11-21 南开大学 A kind of diphyllin derivative and its production and use
CN107595838B (en) * 2017-09-13 2019-10-22 北京理工大学 A kind of Lignanoids compounds are preparing the application in anti-liver fiber drug
WO2019182947A1 (en) * 2018-03-19 2019-09-26 Purdue Research Foundation Arylnaphthalene compounds as vacuolar-atpase inhibitors and the use thereof
US11884653B2 (en) * 2018-03-19 2024-01-30 Purdue Research Foundation Arylnaphthalene compounds as vacuolar-ATPase inhibitors and the use thereof
CN111303137B (en) * 2020-03-05 2022-02-01 南通大学 Diphyllin ether derivative and preparation method and application thereof
JP2023525103A (en) * 2020-05-11 2023-06-14 ゴーダーヴァリ バイオリファイナリーズ リミテッド Use of compounds for treatment of viral infections
CN113018281B (en) * 2021-02-23 2023-02-03 中国人民解放军海军军医大学 Pellino1 natural small-molecule inhibitor and application thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4942516B1 (en) * 1967-03-30 1974-11-15
JPH0717554B2 (en) * 1986-07-23 1995-03-01 株式会社ツムラ Novel lignan derivative and antiulcer agent containing the same as active ingredient
JPH02300124A (en) * 1989-02-28 1990-12-12 Takeda Chem Ind Ltd Preventive and remedy for osteoporosis
JPH0381272A (en) * 1989-08-23 1991-04-05 Yamanouchi Pharmaceut Co Ltd New lignan compound
JPH03120264A (en) * 1989-10-03 1991-05-22 Yamanouchi Pharmaceut Co Ltd Novel lignan compound
JP3099243B2 (en) * 1990-03-22 2000-10-16 武田薬品工業株式会社 Bone resorption inhibitor and naphthalene derivative
JPH0912592A (en) * 1995-06-26 1997-01-14 Taisho Pharmaceut Co Ltd Lignan compound
DE10204637A1 (en) * 2001-02-05 2002-11-07 Greither Salus Haus Dr Otto Pharmaceutical, nutritional or food additive composition containing gamma-linolenic acid, isoflavone and lignan, is effective e.g. against tumors, osteoporosis and premenstrual syndrome
US7008666B2 (en) * 2001-11-26 2006-03-07 Hormos Nutraceutical Oy Ltd. Method of inhibiting overactivity of phagocytes or lymphocytes in an individual
DE10243730A1 (en) * 2002-09-20 2004-04-01 Hubert Wilhelm Prior Using seeds of Linum usitatissimum for oral treatment of degenerative joint disease, particularly arthritis, has analgesic and antiinflammatory effects
EP1608369B1 (en) * 2003-03-28 2013-06-26 Novartis Vaccines and Diagnostics, Inc. Use of organic compounds for immunopotentiation
CA2593335A1 (en) * 2005-01-10 2006-07-13 Hormos Medical Ltd. The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency
CN100455671C (en) * 2006-11-09 2009-01-28 中国科学院长春应用化学研究所 Method for biologic preparing 4, 4 dihydric bowel lactone from burdock glycoside
CN101002814A (en) * 2007-01-12 2007-07-25 苏州大学 Medical use of burdock total lignanoid

Also Published As

Publication number Publication date
WO2008058897A3 (en) 2009-03-26
WO2008058897A2 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
GB0623012D0 (en) Diphyllin and other lignans as a medicament for V-ATPase mediated disease
GB0612020D0 (en) Projectile for administering a medicament
IL192565A0 (en) Medicament for topical use
IL198911A0 (en) Drug delivery
EP1992348A4 (en) Pharmaceutical combination
IL182783A0 (en) Oral nasal cannula
PL1957073T3 (en) Medicinal drug
IL194751A0 (en) Drugs and uses
SI2340809T1 (en) A medicament containing fluoroquinolones
AU2007205298A8 (en) Drug combinations
GB0625783D0 (en) Medicament
EP2083820A4 (en) Pharmaceutical compositions comprising intra- and extra- granular fractions
EP2322207A4 (en) Oxygen-transferring blood substitute and a pharmaceutical composition (variants)
IL197883A0 (en) Combination drug
IL197766A (en) Use of a glycopeptide antibiotic in the preparation of a medicament for the prevention of b. anthracis infection
GB0615064D0 (en) Medicament
GB0613031D0 (en) Medicaments
IL195618A0 (en) Drug administration methods
HU0600097D0 (en) Pharmaceutical composition comprising tacrolimus
GB0615814D0 (en) Medicament
TWM292546U (en) Medicament counter
ZA200708369B (en) Medicament
GB0621308D0 (en) An implement for administering medicine
GB2445733B (en) Medical syringe
GB0622268D0 (en) A medicament

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)